维普中文期刊产品整合服务

Current and emerging therapeutic approaches for colorectal cancer:A comprehensive review

查看全文 作  者:Anil [1]Kumar;Vipasha [1]Gautam;Arushi [1]Sandhu;Kajal [1]Rawat;Antika [1]Sharma;Lekha [1]Saha 高影响力作者 机构地区:[1]Department of Pharmacology,Post Graduate Institute of Medical Education and Research,Chandigarh 160012,India高影响力机构 出  处:《World Journal of Gastrointestinal Surgery》索引2023年第15卷第4期,共25页高影响力期刊 摘  要:Colorectal cancer(CRC)affects 1 in 23 males and 1 in 25 females,making it the third most common cancer.With roughly 608000 deaths worldwide,CRC accounts for 8%of all cancer-related deaths,making it the second most common cause of death due to cancer.Standard and conventional CRC treatments include surgical expurgation for resectable CRC and radiotherapy,chemotherapy,immunotherapy,and their combinational regimen for non-resectable CRC.Despite these tactics,nearly half of patients develop incurable recurring CRC.Cancer cells resist the effects of chemotherapeutic drugs in a variety of ways,including drug inactivation,drug influx and efflux modifications,and ATPbinding cassette transporter overexpression.These constraints necessitate the development of new target-specific therapeutic strategies.Emerging therapeutic approaches,such as targeted immune boosting therapies,non-coding RNA-based therapies,probiotics,natural products,oncolytic viral therapies,and biomarkerdriven therapies,have shown promising results in preclinical and clinical studies.We tethered the entire evolutionary trends in the development of CRC treatments in this review and discussed the potential of new therapies and how they might be used in conjunction with conventional treatments as well as their advantages and drawbacks as future medicines. 关 键 词:Colorectal cancer Chemotherapy IMMUNOTHERAPY RNA interference PROBIOTICS Oncolytic viral therapy
相关文献

参考文献(158)

引证文献(6)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费